SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000919574-20-000098
Filing Date
2020-01-06
Accepted
2020-01-06 18:38:39
Documents
1
Period of Report
2020-01-02

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 11711
  Complete submission text file 0000919574-20-000098.txt   14192
Mailing Address BROADWOOD CAPITAL INC. 724 FIFTH AVENUE, 9TH FLOOR NEW YORK NY 10019
Business Address BROADWOOD CAPITAL INC. 724 FIFTH AVENUE, 9TH FLOOR NEW YORK NY 10019 212-508-5735
BROADWOOD PARTNERS, L.P. (Reporting) CIK: 0001278386 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37648 | Film No.: 20511573

Mailing Address 724 FIFTH AVENUE 9TH FLOOR NEW YORK NY 10019
Business Address 724 FIFTH AVENUE 9TH FLOOR NEW YORK NY 10019 212-508-5735
BROADWOOD CAPITAL INC (Reporting) CIK: 0001278387 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37648 | Film No.: 20511574

Mailing Address
Business Address
BRADSHER NEAL C (Reporting) CIK: 0001278388 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37648 | Film No.: 20511575

Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-775-0515
OncoCyte Corp (Issuer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances